Teleflex wins FDA clearance for mask; Torax ramps up GERD sales;

@FierceMedDev: Dx startup On-Q-ity shuts down. DxExtra story | Follow @FierceMedDev

@MarkHFierce: Altura Medical drew in $6M in new financing for AAA stent graft develpment, according to a regulatory filing. Story | Follow @MarkHFierce

 @DamianFierce: Boston Scientific is launching a new, FDA-approved neuromodulation device for chronic back pain. Article | Follow @DamianFierce

> Torax Medical in Minnesota is gaining traction with its new Linx device, a magnetic bracelet implanted at the base of the throat to treat severe acid reflux. Story

> Teleflex ($TFX) obtained 510(k) clearance for a new device/mask designed to help clinicians reduce their exposure to hazardous waste anesthetic gases. Release

> Amendia, a specialty medical-device manufacturer, plans to invest up to $50 million to help a biomedical spinoff bring to market implant technology designed to stimulate bone regrowth. Story (subs. req.)

> TeVido BioDevices in Texas is developing a 3D inkjet printer that would make a customized breast implant. Story

> Brightstone Venture Capital in Minnesota is on the hunt, in part, for new life sciences investments. Story (subs. required)

> Diagnostics company Veracyte has appointed Shelly Guyer, a veteran of iRhythm Technologies, to be its next CFO. Release

Biotech News

@FierceBiotech: Firm ranks top 5 biotech deals in evolving pharma R&D landscape. Report | Follow @FierceBiotech

@JohnCFierce: Another thought on $GSK: If it gets over tox issue, drisapersen is probably headed for approval, barring a nasty efficacy surprise in Ph3. | Follow @JohnCFierce.

@RyanMFierce: Just heard from ex-FDA CIO Eric Perakslis. We'll have more on his next move soon, hopefully. News on his departure: Story | Follow @RyanMFierce

> Firm ranks top 5 biotech deals in evolving pharma R&D landscape. Report

> Boehringer Ingelheim fuels gene therapy startup focused on eye diseases. Article

> GlaxoSmithKline measures 38-meter leap over placebo in Duchenne walking test. News

Pharma News

@FiercePharma: More layoffs for $LLY: Eli Lilly to cut 100s of sales people in neuroscience, CV and men's health. Report | Follow @FiercePharma

@EricPFierce: C'est la vie. Sanofi finds the politics of downsizing in France a war of attrition. Report | Follow @EricPFierce

> Bristol-Myers, Lilly expand biologics operations. More

> Elan investors approve share buyback but still must decide on buyout. Story

> Roche CEO says no need to buy out Japanese subsidiary Chugai. Item

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.